Presentation | Medical Therapy in Peripheral Artery Disease
Clinical
Dual Pathway Inhibition prescription after percutaneous vascular intervention is low, and dependent on physician and treating facility practice patterns
Disclosures: Rabih Chaer: Financial relationships have not been disclosed at this time. | Marissa Jarosinski: Financial relationships have not been disclosed at this time. | Mikayla Lowenkamp: Financial relationships have not been disclosed at this time. | Natalie Domenick Sridharan: Financial relationships have not been disclosed at this time. | Michael C Madigan: Financial relationships have not been disclosed at this time. | Katherine Reitz: Financial relationships have not been disclosed at this time. |